“Luminal A” and “luminal B” are two neighboring labels that describe patterns in breast cancer test results: both describe cancers with hormone receptors present, and the difference between them is drawn from the growth signs on your pathology report. Luminal B is generally read as the faster-growing pattern of the two. This article sets the two side by side in plain language — what each label means, why the line between them is the softest boundary in the luminal family, and how your care team uses the distinction.
Key Takeaways
- Both luminal A and luminal B describe breast cancers with hormone receptors present (estrogen receptors, progesterone receptors, or both).
- The usual difference is growth: luminal B is generally read as faster-growing, from the growth marker and grade on the pathology report, while luminal A is generally slower-growing.
- HER2 is not high in luminal A; in luminal B it may be not high, or high under some definitions.
- The A/B boundary is drawn from growth signs, and laboratories do not all draw it in exactly the same place — the underlying results matter more than the label.
- Individual cases differ. The label is one layer of your report, alongside type, stage, grade, and lymph node findings.
- Because hormone receptors are present in both patterns, treatments that act on hormones are among the approaches a care team may consider for either.
What the Word “Luminal” Means
The inner lining of the breast’s ducts and lobules is called the luminal layer. When researchers first grouped breast cancers by which genes they switch on, some cancers resembled those lining cells, and that family of groups was named “luminal.” The family has two commonly used members: luminal A and luminal B. Our pillar guide, Types of Breast Cancer Compared, shows where this grouping fits among the other ways a cancer is described — by where it began, by its type, and by its stage.
In everyday practice, the label is usually applied from standard laboratory results rather than gene testing: the hormone receptor results, the HER2 result, and a growth marker often called Ki-67. Both luminal patterns have hormone receptors present. What separates them is what the growth signs suggest.
The Two Patterns, Side by Side
The table below sets out the two patterns in general terms. It describes test-result patterns only — it is not a ranking of how serious a cancer is, because that depends on the full picture in each individual case.
| Luminal A | Luminal B | |
|---|---|---|
| Hormone receptors | Present | Present (progesterone receptor sometimes lower or weaker) |
| HER2 | Not high | Not high, or high in some definitions of the pattern |
| Growth marker (Ki-67) | Generally at the lower end | Generally at the higher end |
| Grade | Often lower | Often higher |
| General growth pattern | Generally slower-growing | Generally faster-growing than luminal A |
Three differences are the ones people meet most often. Growth signs come first: in luminal B, more of the cancer cells appear to be actively dividing, the growth marker sits at the higher end, and the grade is often higher. Progesterone receptor level is second: both patterns have hormone receptors, but the progesterone receptor result is sometimes lower or weaker in luminal B. HER2 is third: in luminal A, HER2 is not high, while luminal B includes, under some definitions, cancers with high HER2 when hormone receptors are present. Our companion articles set out each side of the comparison in the same plain terms: Luminal A Breast Cancer Explained and Luminal B Breast Cancer Explained.
Why the Line Between Them Is Soft
The luminal A/B boundary is the softest in this family, because it is drawn from growth signs rather than from a clear yes-or-no test. A cancer close to the line may be described slightly differently by different teams, without anyone being wrong — the underlying test results are the same, and the results, more than the label, are what planning is built on. Laboratories do not all draw the lower/higher line for the growth marker in exactly the same place, and teams may weigh grade and progesterone receptor level slightly differently.
It also helps to know that these patterns describe biology, not where the cancer began. A luminal A or luminal B cancer can be ductal, lobular, or another type, and those descriptions apply at the same time. Think of the luminal label as one layer of your report rather than the whole of it: many pathology reports list the receptor results without using the words “luminal A” or “luminal B” at all, and the grouping is something your team may refer to in discussion rather than in writing.
What the Distinction Means for Treatment Planning
The practical importance of both patterns starts with the same fact: the cancer cells carry hormone receptors, so approaches that block the hormones or lower their levels are among the tools a care team may consider for either. Our comparison of hormone receptor-positive and triple-negative breast cancer explains why the presence or absence of receptors changes the range of approaches so much. If HER2 is high in a luminal B case, HER2-directed approaches may enter the planning as well — a question explained in general terms in our article on HER2-low breast cancer and its not-high vocabulary.
Whether other treatments, such as chemotherapy, are recommended is a separate and individual judgement. It depends on the cancer’s stage and size, whether lymph nodes are involved, the grade, your age and overall health, and sometimes additional tests your team may discuss with you. This article names no specific medicines and recommends no particular plan, because the right combination and timing belong with your own doctor and care team, who can read the label alongside everything else they know about your case. A faster-growing pattern is information, not a prediction about any one person — and it is not a reason to skip follow-up or monitoring.
Questions to Ask Your Doctor
- Can you walk me through the results that place my cancer in the luminal A or luminal B group?
- What were my estrogen receptor, progesterone receptor, HER2, and Ki-67 results?
- Is my HER2 result in the not-high range, or is it high?
- What were my grade and stage, and how do they fit with this pattern?
- Which parts of my treatment plan follow from the hormone receptors being present?
- What follow-up and monitoring will I have, and what should I watch for between visits?
Frequently Asked Questions
Are luminal A and luminal B separate types of breast cancer?
They are groupings based on biology — the receptor and growth-marker results — rather than descriptions of where the cancer began. A luminal A or luminal B cancer can be ductal, lobular, or another type, and the descriptions apply at the same time. Think of the luminal label as one layer of your report, not a replacement for the others.
Is luminal B worse than luminal A?
The pattern is generally associated with faster growth, but no single label decides how serious a cancer is. Stage — how large it is and whether it has spread — grade, and how the cancer responds to treatment all matter at least as much. Your care team can explain how the pieces fit together in your own case.
Why might two hospitals describe the same cancer differently?
The luminal A/B line is drawn from growth-marker results, and laboratories do not all set that line in the same place. A cancer close to the boundary may be given either label while the underlying results stay identical. This is one reason the individual results on your report matter more than the group name alone.
Where does HER2 fit into this comparison?
In luminal A, HER2 is not high. In luminal B, some definitions include cancers with high HER2 when hormone receptors are also present, while other definitions use the name only for faster-growing cancers whose HER2 is not high. Your team can tell you which reading they use and where your result sits.
Where can I read more?
Our pillar guide compares the main types and patterns side by side. General background on receptor testing and breast cancer biology is also published by the American Cancer Society (cancer.org) and the National Cancer Institute (cancer.gov). Your own report, explained by your own team, is the source that matters most.
Related Articles
- Types of Breast Cancer Compared: A Complete Guide
- Luminal A Breast Cancer Explained
- Luminal B Breast Cancer Explained
- HER2-Low Breast Cancer Explained in Plain English
- Hormone Receptor-Positive vs Triple-Negative Breast Cancer
This article is for general educational purposes only and is not medical, legal, or financial advice. It does not replace professional care. Talk to your doctor or care team about your own situation. If you think you may have a medical emergency, call 911.